<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Drugs.com Blog</title>
	<atom:link href="http://blog.drugs.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.drugs.com</link>
	<description></description>
	<lastBuildDate>Sun, 05 May 2013 23:54:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu</title>
		<link>http://blog.drugs.com/2013/05/q1-2013-drug-sales-data-released-rough-u-s-flu-season-boosts-numbers-for-tamiflu/</link>
		<comments>http://blog.drugs.com/2013/05/q1-2013-drug-sales-data-released-rough-u-s-flu-season-boosts-numbers-for-tamiflu/#comments</comments>
		<pubDate>Sun, 05 May 2013 23:54:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>
		<category><![CDATA[Statistics]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=468</guid>
		<description><![CDATA[The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2013/05/q1-2013-drug-sales-data-released-rough-u-s-flu-season-boosts-numbers-for-tamiflu/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drugs.com Receives Fourth Webby Nomination!</title>
		<link>http://blog.drugs.com/2013/04/drugs-com-receives-fourth-webby-nomination/</link>
		<comments>http://blog.drugs.com/2013/04/drugs-com-receives-fourth-webby-nomination/#comments</comments>
		<pubDate>Wed, 10 Apr 2013 01:31:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=455</guid>
		<description><![CDATA[We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet&#8217;s top 5 health web sites is indeed an honor. But wait, there&#8217;s more&#8230; we need your vote! The [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2013/04/drugs-com-receives-fourth-webby-nomination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drugs.com Launches New iOS and Android Medication Guide</title>
		<link>http://blog.drugs.com/2013/03/drugs-com-launches-new-ios-and-android-app/</link>
		<comments>http://blog.drugs.com/2013/03/drugs-com-launches-new-ios-and-android-app/#comments</comments>
		<pubDate>Fri, 08 Mar 2013 03:06:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Mobile]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=438</guid>
		<description><![CDATA[Today we are officially launching a new consumer tool to join other leading Drugs.com apps &#8211; the Drugs.com Medication Guide. Patients and caregivers will have instant access to their most recent personal medication records, the latest advice on drug therapy and medical conditions, and breaking health news tailored to their needs. In addition, consumers can [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2013/03/drugs-com-launches-new-ios-and-android-app/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Q4 2012 Drug Sales Data Released: Abilify Overtakes Nexium as the Top Drug by Sales</title>
		<link>http://blog.drugs.com/2013/02/q4-2012-drug-sales-data-released/</link>
		<comments>http://blog.drugs.com/2013/02/q4-2012-drug-sales-data-released/#comments</comments>
		<pubDate>Thu, 07 Feb 2013 21:55:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Statistics]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=429</guid>
		<description><![CDATA[The latest U.S. drug sales data have been released by Drugs.com. At the close of 2012, Otsuka&#8217;s antipsychotic Abilify overtakes AstraZeneca&#8217;s acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2013/02/q4-2012-drug-sales-data-released/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drugs.com Pill Reminder featured on Fox Television Orlando</title>
		<link>http://blog.drugs.com/2013/01/drugs-com-pill-reminder-featured-on-fox/</link>
		<comments>http://blog.drugs.com/2013/01/drugs-com-pill-reminder-featured-on-fox/#comments</comments>
		<pubDate>Mon, 28 Jan 2013 23:05:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>
		<category><![CDATA[Mobile]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=414</guid>
		<description><![CDATA[Our popular Pill Reminder app was featured on WOFL Fox 35 Orlando recently. Here&#8217;s what they had to say&#8230; &#8220;People need to take a medicine to keep that blood pressure down and it&#8217;s hard to motivate them,&#8221; said Dr. Timothy Hendrix of Centra Care. &#8220;It&#8217;s hard to remind them to take that everyday if they&#8217;re [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2013/01/drugs-com-pill-reminder-featured-on-fox/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transparency in Clinical Trials: A New Paradigm Shift?</title>
		<link>http://blog.drugs.com/2012/12/transparency-in-clinical-trials-a-new-paradigm-shift/</link>
		<comments>http://blog.drugs.com/2012/12/transparency-in-clinical-trials-a-new-paradigm-shift/#comments</comments>
		<pubDate>Wed, 19 Dec 2012 01:19:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Media]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=402</guid>
		<description><![CDATA[The British Medical Journal (BMJ), a leading, peer-reviewed medical journal, has announced that beginning in January 2013 it will require all authors of drug or device clinical trials who publish in BMJ &#8211; whether industry-funded or not &#8211; to provide detailed scientific study data to anyone with a reasonable request. Although the policy specifics are [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2012/12/transparency-in-clinical-trials-a-new-paradigm-shift/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Q3 2012 Drug Sales Data Released: Nexium and Abilify Remain the Leading Brands</title>
		<link>http://blog.drugs.com/2012/11/q3-2012-drug-sales-data-released-nexium-and-abilify-remain-the-leading-brands/</link>
		<comments>http://blog.drugs.com/2012/11/q3-2012-drug-sales-data-released-nexium-and-abilify-remain-the-leading-brands/#comments</comments>
		<pubDate>Thu, 22 Nov 2012 02:27:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Statistics]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=396</guid>
		<description><![CDATA[The latest U.S. drug sales data has been released by Drugs.com. As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck’s asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. AstraZeneca’s Nexium, not forecast to lose patent protection until May 2014, [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2012/11/q3-2012-drug-sales-data-released-nexium-and-abilify-remain-the-leading-brands/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bristol-Myers Squibb Acquisition Results in $1.8 Billion Loss</title>
		<link>http://blog.drugs.com/2012/08/bristol-myers-squibb-acquisition-results-in-1-8-billion-loss/</link>
		<comments>http://blog.drugs.com/2012/08/bristol-myers-squibb-acquisition-results-in-1-8-billion-loss/#comments</comments>
		<pubDate>Wed, 29 Aug 2012 04:18:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=389</guid>
		<description><![CDATA[Bristol-Myers Squibb (BMS) has announced that they will discontinue all development of their chronic hepatitis C (HCV) treatment BMS-986094, a nucleotide polymerase (NS5B) inhibitor previously in Phase 2 clinical trials. BMS reports that nine study patients were hospitalized with heart and kidney toxicity, with one patient death due to heart failure. The exact cause of [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2012/08/bristol-myers-squibb-acquisition-results-in-1-8-billion-loss/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Q2 2012 Drug Sales Data Released: Loss of Patent Protection Has Significant Effect</title>
		<link>http://blog.drugs.com/2012/08/q2-2012-drug-sales-data-released-loss-of-patent-protection-has-significant-effect/</link>
		<comments>http://blog.drugs.com/2012/08/q2-2012-drug-sales-data-released-loss-of-patent-protection-has-significant-effect/#comments</comments>
		<pubDate>Wed, 22 Aug 2012 04:38:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Media]]></category>
		<category><![CDATA[Statistics]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=380</guid>
		<description><![CDATA[The latest U.S. drug sales data has been released by Drugs.com. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year’s end. [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2012/08/q2-2012-drug-sales-data-released-loss-of-patent-protection-has-significant-effect/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Drugs.com Stats Center Shows Top 100 U.S. Drug Sales Data</title>
		<link>http://blog.drugs.com/2012/07/new-drugs-com-stats-center-shows-top-100-u-s-drug-sales-data/</link>
		<comments>http://blog.drugs.com/2012/07/new-drugs-com-stats-center-shows-top-100-u-s-drug-sales-data/#comments</comments>
		<pubDate>Wed, 18 Jul 2012 23:09:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Statistics]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=370</guid>
		<description><![CDATA[We are pleased to announce our new interactive stats center featuring quarterly sales data for the top 100 prescribed medicines by U.S. National Sales. Users can view charts showing the sales and unit data for the top 5 drugs plus granular data for the top 100, with graphs and links to other useful resources. This [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2012/07/new-drugs-com-stats-center-shows-top-100-u-s-drug-sales-data/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch</title>
		<link>http://blog.drugs.com/2011/09/introducing-my-meds-the-pill-reminder-app-for-iphone-and-ipod-touch/</link>
		<comments>http://blog.drugs.com/2011/09/introducing-my-meds-the-pill-reminder-app-for-iphone-and-ipod-touch/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 04:17:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Mobile]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=344</guid>
		<description><![CDATA[Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2011/09/introducing-my-meds-the-pill-reminder-app-for-iphone-and-ipod-touch/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store</title>
		<link>http://blog.drugs.com/2011/06/drugs-com-pill-identifier-lite-is-now-the-1-paid-medical-app-in-the-apple-app-store/</link>
		<comments>http://blog.drugs.com/2011/06/drugs-com-pill-identifier-lite-is-now-the-1-paid-medical-app-in-the-apple-app-store/#comments</comments>
		<pubDate>Thu, 02 Jun 2011 01:28:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Mobile]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=331</guid>
		<description><![CDATA[We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more information on our growing [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2011/06/drugs-com-pill-identifier-lite-is-now-the-1-paid-medical-app-in-the-apple-app-store/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Pill Identifier Update</title>
		<link>http://blog.drugs.com/2011/05/pill-identifier-update/</link>
		<comments>http://blog.drugs.com/2011/05/pill-identifier-update/#comments</comments>
		<pubDate>Tue, 24 May 2011 23:20:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Site Upgrades]]></category>
		<category><![CDATA[pillid]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=318</guid>
		<description><![CDATA[We have updated the pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2011/05/pill-identifier-update/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>Medication Use While Breastfeeding – More Data Now Online</title>
		<link>http://blog.drugs.com/2010/10/medication-use-while-breastfeeding-%e2%80%93-more-data-now-online/</link>
		<comments>http://blog.drugs.com/2010/10/medication-use-while-breastfeeding-%e2%80%93-more-data-now-online/#comments</comments>
		<pubDate>Tue, 05 Oct 2010 02:52:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Site Upgrades]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=306</guid>
		<description><![CDATA[Our developers and clinical staff have been working busily behind the scenes to add yet more detailed information in our continued effort to increase awareness of potential medication problems. This latest update includes comprehensive information relating to medicine use while breastfeeding (lactating). It includes drug levels and possible effects on the lactating mother and breastfed [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/10/medication-use-while-breastfeeding-%e2%80%93-more-data-now-online/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>New Pill Identifier App for the iPad, iPhone and iPod Touch</title>
		<link>http://blog.drugs.com/2010/09/new-pill-identifier-app-for-the-ipad-iphone-and-ipod-touch/</link>
		<comments>http://blog.drugs.com/2010/09/new-pill-identifier-app-for-the-ipad-iphone-and-ipod-touch/#comments</comments>
		<pubDate>Tue, 21 Sep 2010 02:58:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Mobile]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=296</guid>
		<description><![CDATA[We are proud to announce the new Drugs.com Pill Identifier application for the iPad, iPhone and iPod Touch. The new iPhone Application adds an exciting new dimension by improving convenience and adding offline capabilities. The app features “search as you type” functionality with options for searching by imprint, drug name, shape, color and score. Access [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/09/new-pill-identifier-app-for-the-ipad-iphone-and-ipod-touch/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>New Symptom Checker Released</title>
		<link>http://blog.drugs.com/2010/09/new-symptom-checker-released/</link>
		<comments>http://blog.drugs.com/2010/09/new-symptom-checker-released/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 03:04:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Site Upgrades]]></category>
		<category><![CDATA[Web 2.0]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=277</guid>
		<description><![CDATA[We are proud to announce the release of our new and comprehensive Symptom Checker. This powerful tool utilizes the prestigious and trusted Medical Decision Guides created by the Faculty of the Harvard Medical School. Covering a multitude of medical issues, patients and caregivers can use the step-by-step interactive wizard to help identify the underlying cause [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/09/new-symptom-checker-released/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>July 13 Webinar &#8211; FDA’s Safety Monitoring of Approved Vaccines</title>
		<link>http://blog.drugs.com/2010/07/july-13-webinar-fda%e2%80%99s-safety-monitoring-of-approved-vaccines/</link>
		<comments>http://blog.drugs.com/2010/07/july-13-webinar-fda%e2%80%99s-safety-monitoring-of-approved-vaccines/#comments</comments>
		<pubDate>Wed, 07 Jul 2010 22:19:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=265</guid>
		<description><![CDATA[FDA’s Center for Biologics Evaluation and Research will host a 30-minute webinar on the agency’s efforts to ensure the safety of vaccines. There will be an opportunity to ask questions following the presentation on July 13, 2010, at 2:00 p.m. EDT. More information is available here: http://www.drugs.com/fda-consumer/july-13-webinar-fda-s-safety-monitoring-of-approved-vaccines-147.html See also, timely FDA Consumer Updates here: http://www.drugs.com/fda-consumer]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/07/july-13-webinar-fda%e2%80%99s-safety-monitoring-of-approved-vaccines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Announces Collaboration With Drugs.com</title>
		<link>http://blog.drugs.com/2010/05/drugs-com-furthers-reach-of-fda-consumer-health-information/</link>
		<comments>http://blog.drugs.com/2010/05/drugs-com-furthers-reach-of-fda-consumer-health-information/#comments</comments>
		<pubDate>Wed, 26 May 2010 19:26:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=229</guid>
		<description><![CDATA[A new partnership forged by the two entities provides consumers with a joint resource on Drugs.com that features FDA Consumer Update articles, videos, and slide-shows. It will also bring FDA health information to the Drugs.com’s mobile phone platform at drugs.mobi. “The partnership with Drugs.com means that reliable, useful, and timely health information will be available [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/05/drugs-com-furthers-reach-of-fda-consumer-health-information/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Drugs.com receives another Webby nomination</title>
		<link>http://blog.drugs.com/2010/04/vote-for-drugs-com-as-best-health-website-in-the-14th-annual-webby-awards/</link>
		<comments>http://blog.drugs.com/2010/04/vote-for-drugs-com-as-best-health-website-in-the-14th-annual-webby-awards/#comments</comments>
		<pubDate>Tue, 13 Apr 2010 23:14:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=213</guid>
		<description><![CDATA[We are extremely proud to announce that Drugs.com has been nominated for a second prestigious Webby Award. To be judged among the Internet&#8217;s top 5 health web sites is indeed an honor. The Webby People’s Voice Awards is also one of the few major awards that invite the public to participate by allowing you to [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/04/vote-for-drugs-com-as-best-health-website-in-the-14th-annual-webby-awards/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Drugs.com Enters Exclusive Agreement to Publish Premium 3D &#8220;Mechanism of Action&#8221; Content</title>
		<link>http://blog.drugs.com/2010/04/drugs-com-enters-exclusive-agreement-to-publish-premium-3d-mechanism-of-action-content/</link>
		<comments>http://blog.drugs.com/2010/04/drugs-com-enters-exclusive-agreement-to-publish-premium-3d-mechanism-of-action-content/#comments</comments>
		<pubDate>Thu, 08 Apr 2010 04:04:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=200</guid>
		<description><![CDATA[Drugs.com has entered into an exclusive content partnership with Understand.com to provide pharmaceutical companies a new, premium educational 3D animation solution on the Drugs.com web site. This PhRMA compliant educational initiative enhances current drug-specific product information on Drugs.com with interactive 3D animations explaining how a drug’s mechanism of action works and how the product specifically [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/04/drugs-com-enters-exclusive-agreement-to-publish-premium-3d-mechanism-of-action-content/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Drugs.com and WebMD enter into premium display advertising agreement</title>
		<link>http://blog.drugs.com/2010/01/drugs-com-and-webmd-enter-into-premium-display-advertising-agreement/</link>
		<comments>http://blog.drugs.com/2010/01/drugs-com-and-webmd-enter-into-premium-display-advertising-agreement/#comments</comments>
		<pubDate>Fri, 01 Jan 2010 05:01:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=190</guid>
		<description><![CDATA[Effective January 1, 2010, Drugs.com has entered into an exclusive advertising agreement with WebMD. All premium, consumer focused display or &#8220;banner&#8221; advertising will be provided exclusively by WebMD. &#8220;Drugs.com is one of very few sites that have developed a loyal base of users that are of high interest and high value to biopharmaceutical and consumer [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2010/01/drugs-com-and-webmd-enter-into-premium-display-advertising-agreement/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Rx/OTC status, Approval History, CSA and Pregnancy information now available.</title>
		<link>http://blog.drugs.com/2009/12/rxotc-status-approval-history-csa-and-pregnancy-information-now-available/</link>
		<comments>http://blog.drugs.com/2009/12/rxotc-status-approval-history-csa-and-pregnancy-information-now-available/#comments</comments>
		<pubDate>Mon, 21 Dec 2009 21:57:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=180</guid>
		<description><![CDATA[Following on from our recent interface update, we have now added information for FDA Approval History, Rx/OTC status, Pregnancy Category and CSA (Controlled Substances Act) for many medications. Simply search for any drug and the information available is displayed in the right hand column of any drug information page.]]></description>
		<wfw:commentRss>http://blog.drugs.com/2009/12/rxotc-status-approval-history-csa-and-pregnancy-information-now-available/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New, simpler interface update now live</title>
		<link>http://blog.drugs.com/2009/12/new-simpler-interface-update-now-live/</link>
		<comments>http://blog.drugs.com/2009/12/new-simpler-interface-update-now-live/#comments</comments>
		<pubDate>Fri, 18 Dec 2009 21:37:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=174</guid>
		<description><![CDATA[Regular users will notice that we have now completed rolling out a significant change to the design and layout of Drugs.com. There are many improvements in this new release, including; a less complex two column layout making the content easier to scan and read; increasing the default font size and adding related links in easier [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2009/12/new-simpler-interface-update-now-live/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Drugs.com Answers &#8211; got a question about your meds?</title>
		<link>http://blog.drugs.com/2009/12/drugs-com-answers-got-a-question-about-your-meds/</link>
		<comments>http://blog.drugs.com/2009/12/drugs-com-answers-got-a-question-about-your-meds/#comments</comments>
		<pubDate>Fri, 04 Dec 2009 03:19:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/?p=141</guid>
		<description><![CDATA[The new Drugs.com Answers and Support Group system is intended as a way of providing help for people who have questions about drugs or medical conditions. Members of Drugs.com can ask or answer questions and join support groups. We&#8217;d also like to take this opportunity to invite members to share their own knowledge with other [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2009/12/drugs-com-answers-got-a-question-about-your-meds/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Drugs.com Refutes Erroneous Claims</title>
		<link>http://blog.drugs.com/2009/11/drugs-com-refutes-erroneous-claims/</link>
		<comments>http://blog.drugs.com/2009/11/drugs-com-refutes-erroneous-claims/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 23:07:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Media]]></category>
		<category><![CDATA[Drugs.com FDA public hearings]]></category>

		<guid isPermaLink="false">http://blog.drugs.com/2009/11/drugs-com-refutes-erroneous-claims/</guid>
		<description><![CDATA[This week in Washington, D.C. saw the public hearings on promotion of FDA-regulated medical products using the internet and social media tools. Drugs.com got a mention and a reference or two by one of the speakers. People heard, wrote, tweeted, blogged, reported and within minutes the quote had gone viral on the internet. The problem [...]]]></description>
		<wfw:commentRss>http://blog.drugs.com/2009/11/drugs-com-refutes-erroneous-claims/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
